Moderna and Vertex enter new collaboration to develop gene-editing therapies for CF Sep. 18, 2020 No Comments
AVM receives FDA clearance to study AVM-0703 for COVID-19- and influenza-related ARDS Sep. 17, 2020 No Comments
Profiling of JAK inhibitors AZD-4604 and AZD-0449 in translational rodent model of asthma Sep. 15, 2020 No Comments
Results from a phase IIa POC trial of the oral adenosine A1 receptor antagonist PBF-680 Sep. 9, 2020 No Comments
First phase I data presented for the neutrophil elastase inhibitor BI-1323495 Sep. 9, 2020 No Comments